/

Naveris

Develops molecular diagnostic blood tests for early cancer detection.

BiotechnologyHealthcare naveris.com ↗

Company facts

Founded: 2017
Employees: 112
Headquarters: United States
Type: Private
Funding: Series B · $17.5M · 2024